| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 732830 | N1-(4-fluorophenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihyd ro-1H-3-pyrrolylamino)benzamide | 0.0178844438004194 | 0.29297647 |
| NSC 742860 | Null | 0.0178844438004194 | 0.42360923 |
| NSC 743434 | 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one | 0.0178844438004194 | 0.46981202 |
| NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 0.0178844438004194 | 0.43204923 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0178844438004195 | 0.5100677 |
| NSC 127328 | Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- | 0.0178844438004195 | 0.045422754 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0178844438004195 | 0.51334027 |
| NSC 215721 | Null | 0.0178844438004195 | 0.15686443 |
| NSC 335789 | 3-Azabicyclo[3.2.1]nonane-3-carbothioic acid, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide | 0.0178844438004195 | 0.48931706 |
| NSC 348977 | 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide, dihydrochloride | 0.0178844438004195 | 0.32052854 |